Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.35%1.02B | 11.71%2.52B | 4.37%1.12B | 10.61%2.26B | 5.02%1.07B | 25.45%2.04B | 98.97%1.02B | 42.69%1.63B | -9.59%511.4M | -20.25%1.14B |
| Operating income | -8.35%1.02B | 11.71%2.52B | 4.37%1.12B | 10.61%2.26B | 5.02%1.07B | 25.45%2.04B | 98.97%1.02B | 42.69%1.63B | -9.59%511.4M | -20.25%1.14B |
| Cost of sales | 7.76%-834.88M | -12.71%-2.05B | -5.15%-905.11M | -9.44%-1.82B | -1.61%-860.76M | -25.19%-1.66B | -109.54%-847.12M | -51.29%-1.33B | 7.28%-404.27M | 19.41%-878.58M |
| Operating expenses | 7.76%-834.88M | -12.71%-2.05B | -5.15%-905.11M | -9.44%-1.82B | -1.61%-860.76M | -25.19%-1.66B | -109.54%-847.12M | -51.29%-1.33B | 7.28%-404.27M | 19.41%-878.58M |
| Gross profit | -10.89%187.33M | 7.50%467.31M | 1.15%210.21M | 15.76%434.7M | 21.95%207.83M | 26.63%375.53M | 59.08%170.42M | 13.73%296.56M | -17.37%107.13M | -22.93%260.76M |
| Selling expenses | 11.35%-58.85M | -21.72%-131.16M | -20.69%-66.39M | 8.98%-107.76M | 7.65%-55.01M | -14.12%-118.39M | -31.69%-59.56M | -11.06%-103.74M | 3.91%-45.23M | 18.57%-93.41M |
| Administrative expenses | 18.37%-41M | -37.79%-99.84M | -76.73%-50.22M | -19.55%-72.46M | -6.34%-28.42M | -29.43%-60.61M | -39.90%-26.72M | -19.42%-46.83M | -4.03%-19.1M | 13.60%-39.22M |
| Research and development expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -23.01%-36.6M | ---- |
| Impairment and provision | ---8.38M | 73.54%-7.04M | ---- | ---26.62M | ---- | ---- | ---- | ---3.37M | ---- | ---- |
| -Other impairment is provision | ---8.38M | 73.54%-7.04M | ---- | ---26.62M | ---- | ---- | ---- | ---3.37M | ---- | ---- |
| Special items of operating profit | -83.57%-47.94M | -24.87%-89.09M | 62.11%-26.12M | 33.75%-71.35M | -43.14%-68.92M | -74.19%-107.69M | -496.35%-48.15M | -45.22%-61.82M | 199.63%12.15M | -30.74%-42.57M |
| Operating profit | -53.83%31.16M | -10.45%140.17M | 21.62%67.49M | 76.19%156.52M | 54.18%55.49M | 9.94%88.83M | 96.15%35.99M | -5.57%80.8M | -52.37%18.35M | -41.01%85.57M |
| Financing cost | -30.40%-31.16M | -66.07%-51.47M | -317.82%-23.89M | -160.86%-30.99M | 15.20%-5.72M | -66.35%-11.88M | -70.06%-6.74M | 44.91%-7.14M | 42.97%-3.97M | 13.71%-12.96M |
| Share of profits of associates | ---- | 200.00%24K | ---- | --8K | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | -99.99%6K | -29.32%88.72M | -12.41%43.6M | 63.13%125.53M | 70.17%49.78M | 4.47%76.95M | 103.34%29.25M | 1.45%73.66M | -54.44%14.39M | -44.16%72.6M |
| Tax | -595.12%-71.1M | 27.90%-15.4M | -13.03%-10.23M | -140.75%-21.36M | -66.89%-9.05M | 17.35%-8.87M | -245.35%-5.42M | 11.86%-10.73M | 74.48%-1.57M | 26.46%-12.18M |
| After-tax profit from continuing operations | -313.03%-71.09M | -29.62%73.32M | -18.06%33.37M | 53.01%104.18M | 70.92%40.73M | 8.20%68.08M | 85.94%23.83M | 4.13%62.92M | -49.59%12.82M | -46.75%60.43M |
| Earning after tax | -313.03%-71.09M | -29.62%73.32M | -18.06%33.37M | 53.01%104.18M | 70.92%40.73M | 8.20%68.08M | 85.94%23.83M | 4.13%62.92M | -49.59%12.82M | -46.75%60.43M |
| Minority profit | -109.89%-671K | -9.69%31.13M | 172.10%6.78M | 669.49%34.47M | -47.32%-9.41M | 153.47%4.48M | -110.83%-6.39M | -860.89%-8.38M | ---3.03M | ---872K |
| Profit attributable to shareholders | -364.85%-70.42M | -39.47%42.19M | -46.96%26.59M | 9.59%69.7M | 65.93%50.13M | -10.80%63.6M | 90.70%30.21M | 16.32%71.3M | -37.68%15.84M | -45.98%61.3M |
| Dividend per share | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -45.89%0.0158 |
| Basic earnings per share | -333.85%-0.152 | -46.11%0.097 | -49.61%0.065 | 9.76%0.18 | 65.38%0.129 | -10.87%0.164 | 90.24%0.078 | 16.46%0.184 | -37.88%0.041 | -45.89%0.158 |
| Diluted earnings per share | -333.85%-0.152 | -46.11%0.097 | -49.61%0.065 | 9.76%0.18 | 65.38%0.129 | -10.87%0.164 | 90.24%0.078 | 16.46%0.184 | -37.88%0.041 | -45.89%0.158 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Nexia Singapore PAC, Yung Cheng (Hong Kong) Certified Public Accountants Limited | -- | KPMG LLP | -- | KPMG LLP | -- | KPMG LLP | -- | KPMG LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.